Boothbay Fund Management »

Neuphoria Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Neuphoria Therapeutics (NEUP) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Neuphoria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neuphoria Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuphoria Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $54k 14k 3.88

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Neuphoria Therapeutics

Lynx1 Capital Management
None
AdvisorShares Investments
Ikarian Capital
ADAR1 Capital Management
Prosperity Wealth Management
FNY Investment Advisers
Diadema Partners
Vanguard Group
Millennium Management
Geode Capital Management
Jane Street
Boothbay Fund Management
XTX Topco
Commonwealth Equity Services

View all funds holding Neuphoria Therapeutics